Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, April 10, 2019
[ Wed, Apr 10th 2019
] - WOPRAI
[ Wed, Apr 10th 2019
] - WOPRAI
[ Wed, Apr 10th 2019
] - WOPRAI
[ Wed, Apr 10th 2019
] - WOPRAI
Tue, April 9, 2019
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
Mon, April 8, 2019
[ Mon, Apr 08th 2019
] - WOPRAI
Marc Goodman Initiated (AXSM) at Buy and Held Target at $25 on, Apr 8th, 2019
Marc Goodman of SVB Leerink, Initiated "Axsome Therapeutics, Inc." (AXSM) at Buy and Held Target at $25 on, Apr 8th, 2019.
Marc has made no other calls on AXSM in the last 4 months.
There is 1 other peer that has a rating on AXSM. Out of the 1 peers that are also analyzing AXSM, 0 agree with Marc's Rating of Hold.
This is the rating of the analyst that currently disagrees with Marc
- Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $25 on, Thursday, March 21st, 2019
Similar Stocks and Investing Articles
[ Tue, Oct 16th 2018
] - WOPRAI
[ Fri, Sep 21st 2018
] - WOPRAI
[ Wed, Feb 28th 2018
] - WOPRAI
[ Wed, Oct 25th 2017
] - WOPRAI
[ Fri, Jul 18th 2014
] - WOPRAI
[ Wed, Apr 30th 2014
] - WOPRAI
[ Wed, Apr 23rd 2014
] - WOPRAI
[ Mon, Apr 21st 2014
] - WOPRAI
[ Fri, Apr 19th 2013
] - WOPRAI
[ Tue, Apr 16th 2013
] - WOPRAI